Publikationen, an denen er mitarbeitet María Sanjurjo Sáez (10)

2022

  1. A smartphone app to improve the safety of patients undergoing treatment with oral antineoplastic agents: 4 years of experience in a university hospital

    Frontiers in Public Health, Vol. 10

2021

  1. Chimeric Antigen Receptor T Cell Therapy Management and Safety: A Practical Tool From a Multidisciplinary Team Perspective

    Frontiers in Oncology, Vol. 11

  2. Dpyd exome, mrna expression and uracil levels in early severe toxicity to fluoropyrimidines: An extreme phenotype approach

    Journal of Personalized Medicine, Vol. 11, Núm. 8

  3. Tocilizumab as salvage treatment of refractory pulmonary acute graft-versus-host disease

    Journal of Oncology Pharmacy Practice, Vol. 27, Núm. 3, pp. 751-755

2020

  1. Risks and medication errors analysis to evaluate the impact of a chemotherapy compounding workflow management system on cancer patients’ safety

    Health Informatics Journal, Vol. 26, Núm. 3, pp. 1995-2010

2019

  1. Drug safety surveillance within a strategy for the management of non-chemotherapy drug-induced neutropenia

    International Journal of Clinical Pharmacy, Vol. 41, Núm. 5, pp. 1143-1147

  2. Oral antineoplastic agents: assessment of safety and dose adjustments in clinical practice

    Expert Opinion on Drug Safety, Vol. 18, Núm. 9, pp. 861-868

2018

  1. Concomitant use of sorafenib with ombitasvir/paritaprevir/ritonavir and dasabuvir: Effectiveness and safety in clinical practice

    Journal of Clinical Pharmacy and Therapeutics, Vol. 43, Núm. 6, pp. 906-909

  2. Effectiveness, Safety, and Costs of a Treatment Switch to Dolutegravir Plus Rilpivirine Dual Therapy in Treatment-Experienced HIV Patients

    Annals of Pharmacotherapy, Vol. 52, Núm. 1, pp. 11-18

  3. Pazopanib-Associated Transient Ischemic Attack

    American journal of therapeutics, Vol. 25, Núm. 3, pp. e393-e394